HCAT
Get informed when a big investor buys or sells
+ FollowUndervalued by 72.1% based on the discounted cash flow analysis.
| Market cap | $113.06 Million |
|---|---|
| Enterprise Value | $113.13 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.55 |
| Beta | 1.56 |
| Outstanding Shares | 73,960,000 |
| P/E Ratio | -0.42 |
|---|---|
| PEG | 38.63 |
| Price to Sales | 0.57 |
| Price to Book Ratio | 1.71 |
| Enterprise Value to Revenue | 0.39 |
| Enterprise Value to EBIT | -0.71 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.54 |
| Debt to Equity | 0.6 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.4241▼ 632.59% |
|---|---|
| Total Calls | 2,478,600▲ 12293.00% |
| Total Puts | 1,051,100▲ 678.59% |
Holdings and activity of institutional investors.
| Ownership % | 78.64%▼ 0.41% |
|---|---|
| Total Invested | $70.92M▼ 46.29% |
| Investors Holding | 139▲ 2.00% |
No data